Navitoclax-piperazine T12186
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Navitoclax-piperazine is an inhibitor of B-cell lymphoma extra large (BCL-XL).
CAS nr:
2143096-93-7
Purity:
98%
Molecular Weight:
973,63
SMILES:
CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCNCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C
Formula:
C47H56ClF3N6O5S3
Pathway:
Apoptosis
Target:
BCL
